Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews.
Front Pharmacol
; 12: 792877, 2021.
Article
in En
| MEDLINE
| ID: mdl-35087406
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Pharmacol
Year:
2021
Document type:
Article
Affiliation country:
South Korea
Country of publication:
Switzerland